These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7315841)

  • 1. A simplified method for monitoring heparin therapy at the bedside: the activated whole blood clotting time.
    Forman WB; Bayer G
    Am J Hematol; 1981 Nov; 11(3):277-81. PubMed ID: 7315841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-blood clotting time, activated partial thromboplastin time, and whole-blood recalcification time as heparin monitoring tests.
    Ts'ao CH; Galluzzo TS; Lo R; Peterson KG
    Am J Clin Pathol; 1979 Jan; 71(1):17-21. PubMed ID: 420167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clotting, activated partial thromboplastin and coagulation times in monitoring heparin therapy.
    Kurec AS; Morris MW; Davey FR
    Ann Clin Lab Sci; 1979; 9(6):494-500. PubMed ID: 518012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PiCT
    Brisset AC; Ferrández A; Krause M; Rathbun S; Marlar R; Korte W
    J Thromb Haemost; 2016 Nov; 14(11):2187-2193. PubMed ID: 27582411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monitoring heparin therapy by thrombin time and activated partial thromboplastin time--a comparison].
    Lang M; Fey MF; Furlan M; Beck EA
    Schweiz Med Wochenschr; 1986 Nov; 116(48):1681-4. PubMed ID: 3798064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activated partial thromboplastin time as a monitor of heparin therapy: a warning.
    Makary AZ; Waterbury L
    Johns Hopkins Med J; 1977 Jun; 140(6):311-5. PubMed ID: 864903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring heparin therapy with the activated partial thromboplastin time.
    Stuart RK; Michel A
    Can Med Assoc J; 1971 Mar; 104(5):385-8. PubMed ID: 5557913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bedside monitoring of heparin therapy: comparison of activated clotting time to activated partial thromboplastin time.
    Reiner JS; Coyne KS; Lundergan CF; Ross AM
    Cathet Cardiovasc Diagn; 1994 May; 32(1):49-52. PubMed ID: 8039220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated clotting time versus activated partial thromboplastin time for therapeutic monitoring of heparin.
    Simko RJ; Tsung FF; Stanek EJ
    Ann Pharmacother; 1995 Oct; 29(10):1015-21; quiz 1061. PubMed ID: 8845539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.
    Levine MN; Hirsh J; Gent M; Turpie AG; Cruickshank M; Weitz J; Anderson D; Johnson M
    Arch Intern Med; 1994 Jan; 154(1):49-56. PubMed ID: 8267489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of red blood cell transfusion utilization between anti-activated factor X and activated partial thromboplastin monitoring in patients receiving unfractionated heparin.
    Belk KW; Laposata M; Craver C
    J Thromb Haemost; 2016 Nov; 14(11):2148-2157. PubMed ID: 27543785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bedside monitoring of heparin therapy.
    Mollitt DL; Gartner DJ; Madura JA
    Am J Surg; 1978 Jun; 135(6):801-3. PubMed ID: 665905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitor.
    Despotis GJ; Hogue CW; Santoro SA; Joist JH; Barnes PW; Lappas DG
    Crit Care Med; 1995 Oct; 23(10):1674-9. PubMed ID: 7587232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the activated clotting time and activated partial thromboplastin time for the monitoring of heparin in adult extracorporeal membrane oxygenation patients.
    Atallah S; Liebl M; Fitousis K; Bostan F; Masud F
    Perfusion; 2014 Sep; 29(5):456-61. PubMed ID: 24570077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between activated clotting time and activated partial thromboplastin times.
    Smythe MA; Koerber JM; Nowak SN; Mattson JC; Begle RL; Westley SJ; Balasubramaniam M
    Ann Pharmacother; 2002 Jan; 36(1):7-11. PubMed ID: 11816262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin monitoring during coronary intervention: activated clotting time versus activated partial thromboplastin time.
    Nath FC; Muller DW; Rosenschein U; Ellis SG; Topol EJ
    Can J Cardiol; 1993 Nov; 9(9):797-801. PubMed ID: 8281479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of activated clotting time and activated partial thromboplastin time to plasma heparin concentration.
    Koerber JM; Smythe MA; Begle RL; Mattson JC; Kershaw BP; Westley SJ
    Pharmacotherapy; 1999 Aug; 19(8):922-31. PubMed ID: 10453963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin monitoring by activated partial thromboplastin time. Comparison of ex vivo measurement and in vitro standardization.
    Scialla SJ
    Am J Clin Pathol; 1985 Sep; 84(3):351-4. PubMed ID: 4036867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bedside coagulation monitoring in heparin-treated patients with active thromboembolic disease: a coronary care unit experience.
    Becker RC; Cyr J; Corrao JM; Ball SP
    Am Heart J; 1994 Oct; 128(4):719-23. PubMed ID: 7942443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring anticoagulation following intracoronary procedures: which method?
    Brack MJ; More RS; Forbat LN; Hubner PJ; Gershlick AH
    Int J Cardiol; 1994 Jun; 45(2):103-8. PubMed ID: 7960247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.